Lbp Am Sa Has $17.25 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS)

LBP AM SA trimmed its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 7.1% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 104,787 shares of the company's stock after selling 8,014 shares during the quarter. LBP AM SA's holdings in Zoetis were worth $17,253,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Zoetis by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 41,366,877 shares of the company's stock valued at $6,739,905,000 after acquiring an additional 120,158 shares during the period. Geode Capital Management LLC lifted its position in shares of Zoetis by 1.8% during the 4th quarter. Geode Capital Management LLC now owns 10,617,897 shares of the company's stock valued at $1,726,075,000 after acquiring an additional 190,137 shares during the period. Polen Capital Management LLC lifted its position in shares of Zoetis by 17.5% during the 4th quarter. Polen Capital Management LLC now owns 7,483,194 shares of the company's stock valued at $1,219,237,000 after acquiring an additional 1,116,541 shares during the period. Wellington Management Group LLP lifted its position in shares of Zoetis by 78.5% during the 4th quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company's stock valued at $1,133,755,000 after acquiring an additional 3,059,255 shares during the period. Finally, Northern Trust Corp lifted its position in shares of Zoetis by 13.3% during the 4th quarter. Northern Trust Corp now owns 6,426,394 shares of the company's stock valued at $1,047,052,000 after acquiring an additional 755,893 shares during the period. 92.80% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ZTS has been the subject of a number of recent analyst reports. Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and cut their target price for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Piper Sandler upped their price objective on Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. Finally, UBS Group dropped their price objective on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $212.13.

Zoetis Trading Up 0.3%

Zoetis stock traded up $0.54 during trading hours on Thursday, hitting $158.81. The stock had a trading volume of 3,491,008 shares, compared to its average volume of 2,590,248. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 1.12. The stock has a market cap of $70.70 billion, a price-to-earnings ratio of 28.51, a P/E/G ratio of 2.62 and a beta of 0.91. Zoetis Inc. has a one year low of $139.70 and a one year high of $200.33. The business's 50 day simple moving average is $161.37 and its 200-day simple moving average is $161.93.

Zoetis (NYSE:ZTS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.40 by $0.08. The firm had revenue of $2.22 billion during the quarter, compared to the consensus estimate of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The business's quarterly revenue was up 1.4% on a year-over-year basis. During the same period last year, the company earned $1.38 earnings per share. On average, equities analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 annualized dividend and a yield of 1.26%. Zoetis's dividend payout ratio is presently 35.91%.

Insider Buying and Selling

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the completion of the transaction, the executive vice president directly owned 15,129 shares in the company, valued at approximately $2,571,930. This trade represents a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.18% of the company's stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.